{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:15:48Z","timestamp":1790241348078,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jaci.2025.10.010","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:55:45Z","timestamp":1761378945000},"page":"409-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation"],"prefix":"10.1016","volume":"157","author":[{"given":"Karin","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Alvarez-Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Hirdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Ru\u00ebff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanai","family":"Pongdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive E.","family":"Grattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Jurcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Barete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Wedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Zakharyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Hoehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Bulai","family":"Livideanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Sabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.10.010_bib1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3389\/fimmu.2017.00792","article-title":"Insights in anaphylaxis and clonal mast cell disorders","volume":"8","author":"Gonz\u00e1lez-de-Olano","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/all.15911","article-title":"Clinical impact of the TPSAB1 genotype in mast cell diseases: a REMA study in a cohort of 959 individuals","volume":"79","author":"Gonz\u00e1lez-de-Olano","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaip.2017.03.019","article-title":"Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients","volume":"5","author":"Vos","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11882-014-0450-8","article-title":"Anaphylaxis as a clinical manifestation of clonal mast cell disorders","volume":"14","author":"Matito","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2025.10.010_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaip.2024.08.025","article-title":"Risk factors for severe sting reactions and side effects during venom immunotherapy","volume":"13","author":"Sturm","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2024.08.034","article-title":"Mast cell disorders and Hymenoptera venom-triggered anaphylaxis: evaluation and management","volume":"13","author":"Boggs","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib11","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jaci.2021.04.013","article-title":"Prevalence of mastocytosis and Hymenoptera venom allergy in the United States","volume":"148","author":"Schuler","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib12","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/all.16132","article-title":"Prevalence of hypersensitivity reactions in various forms of mastocytosis: a pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry","volume":"79","author":"Niedoszytko","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pathmechdis-031521-042618","article-title":"New insights into the pathogenesis of mastocytosis: emerging concepts in diagnosis and therapy","volume":"18","author":"Valent","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2025.10.010_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaci.2025.10.010_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.iac.2023.04.011","article-title":"World Health Organization classification and diagnosis of mastocytosis: update 2023 and future perspectives","volume":"43","author":"Valent","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2025.10.010_bib16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.10.010_bib17","series-title":"The 5th edition of the World Health Organization classification of hematolymphoid tumors","first-page":"1","author":"Li","year":"2022"},{"key":"10.1016\/j.jaci.2025.10.010_bib18","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.jaip.2024.08.044","article-title":"Harmonization of diagnostic criteria in mastocytosis for use in clinical practice: WHO vs ICC vs AIM\/ECNM","volume":"12","author":"Valent","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2025.10.010_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2025.10.010_bib21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"van Doormaal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib22","doi-asserted-by":"crossref","DOI":"10.2340\/1651-226X.2024.31406","article-title":"Epidemiology of mastocytosis: a population-based study (Sweden)","volume":"63","author":"Bergstr\u00f6m","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jaci.2025.10.010_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaip.2019.08.022","article-title":"Mast cell activation syndrome: tools for diagnosis and differential diagnosis","volume":"8","author":"Weiler","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","article-title":"Mast cell activation syndromes","volume":"140","author":"Akin","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11882-024-01126-0","article-title":"Using the right criteria for MCAS","volume":"24","author":"Gulen","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2025.10.010_bib27","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.jaip.2019.05.027","article-title":"Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: a prospective study in 178 patients from 5 tertiary centers in Spain","volume":"7","author":"Gonz\u00e1lez-de-Olano","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib28","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.10.010_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Kristensen","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jaci.2025.10.010_bib30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajh.26962","article-title":"Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management","volume":"98","author":"Pardanani","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2025.10.010_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2025.10.010_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib33","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jaip.2023.08.008","article-title":"The normal range of baseline tryptase should be 1 to 15 ng\/mL and covers healthy individuals with H\u03b1T","volume":"11","author":"Valent","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2022.09.038","article-title":"Disease correlates and clinical relevance of hereditary alpha-tryptasemia in patients with systemic mastocytosis","volume":"151","author":"Sordi","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ACI.0000000000000849","article-title":"Hereditary alpha-tryptasemia","volume":"22","author":"Bonadonna","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.anai.2021.12.008","article-title":"Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in trans","volume":"128","author":"Glover","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.23822\/EurAnnACI.1764-1489.288","article-title":"Defining hereditary alpha-tryptasemia as a risk\/modifying factor for anaphylaxis: are we there yet?","volume":"55","author":"Couto","year":"2023","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.10.010_bib40","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2025.10.010_bib41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jaip.2022.11.042","article-title":"Mast cell activation syndromes: comparison between two scoring models to predict for mast cell clonality","volume":"11","author":"Rama","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib42","article-title":"Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders","volume":"3","author":"Vazquez","year":"2022","journal-title":"HGG Adv"},{"key":"10.1016\/j.jaci.2025.10.010_bib43","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2022007936","article-title":"Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms","volume":"7","author":"Chovanec","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2025.10.010_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib46","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","article-title":"The presence of mast cell clonality in patients with unexplained anaphylaxis","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11882-021-00988-y","article-title":"Idiopathic anaphylaxis: a perplexing diagnostic challenge for allergists","volume":"21","author":"Gulen","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2025.10.010_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2025.1592001","article-title":"Defining \u201cnormal\u201d basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis","volume":"6","author":"Crupi","year":"2025","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010885","article-title":"Detection of KIT mutations in systemic mastocytosis: how, when, and why","volume":"25","author":"Cilloni","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.10.010_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2017.277897","article-title":"Digital PCR: a sensitive and precise method for KIT D816V quantification in mastocytosis","volume":"64","author":"Greiner","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaci.2025.10.010_bib51","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/all.15584","article-title":"KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes","volume":"78","author":"Navarro-Navarro","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2020-136930","volume":"136","author":"George","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.10.010_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2025.10.010_bib54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.10.010_bib56","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.10.010_bib57","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.jaip.2021.04.062","article-title":"Diagnosis of primary mast cell disorders in anaphylaxis: value of KIT D816V in peripheral blood","volume":"9","author":"De Puysseleyr","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib58","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jaip.2022.03.001","article-title":"Standards of genetic testing in the diagnosis and prognostication of systemic mastocytosis in 2022: recommendations of the EU-US Cooperative Group","volume":"10","author":"Hoermann","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.010_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2024.12.970","article-title":"Responses to avapritinib in patients without detectable KIT mutations by ddPCR in peripheral blood highlight diagnostic challenges and opportunities in indolent systemic mastocytosis","volume":"155","author":"Pongdee","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib60","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2024-207798","article-title":"Ultra-sensitive KIT testing uncovers previously undetected KIT mutations in patients with indolent systemic mastocytosis: results from the Pioneer trial","volume":"144","author":"Radia","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.10.010_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/modpathol.2013.117","article-title":"Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis","volume":"27","author":"Berezowska","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2025.10.010_bib62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone","volume":"148","author":"\u0160elb","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.2023023347","article-title":"Standardized indolent systemic mastocytosis evaluations across a health care system: implications for screening accuracy","volume":"144","author":"McMurray","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.10.010_bib64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjd.20098","article-title":"Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL\u22121: why we should investigate further","volume":"185","author":"Jendoubi","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.10.010_bib65","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/all.16084","article-title":"High burden of clonal mast cell disorders and hereditary alpha-tryptasemia in patients who need Hymenoptera venom immunotherapy","volume":"79","author":"Koro\u0161ec","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12174","article-title":"Detection of clonal mast cell disease in wasp venom allergic patients with normal tryptase","volume":"12","author":"Onnes","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib68","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.10.010_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1461359","article-title":"Hereditary alpha tryptasemia: elevated tryptase, female sex, thyroid disorders, and anaphylaxis","volume":"5","author":"Puxkandl","year":"2024","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2025.10.010_bib70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.anai.2021.06.019","article-title":"Inherited and acquired determinants of serum tryptase levels in humans","volume":"127","author":"Lyons","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2025.10.010_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2500\/aap.2025.46.240088","article-title":"Appraisal of the evidence linking hereditary alpha-tryptasemia with mast cell disorders, hypermobility and dysautonomia","volume":"46","author":"Lyons","year":"2025","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2025.10.010_bib72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/bja\/aew251","article-title":"Perioperative anaphylaxis grading system: \u201cmaking the grade.\u201d","volume":"117","author":"Rose","year":"2016","journal-title":"Br J Anaesth"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925010401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925010401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:55:20Z","timestamp":1781006120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925010401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0091674925010401"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.010","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}